- Supported exchanges /
- SHE /
- 300966.SHE
Hubei Goto Biopharm Co.Ltd. (300966 SHE) stock market data APIs
¥17.95
-0.21(-1.2%)
as of November 25, 2024
Price chart is built with Anychart
Hubei Goto Biopharm Co.,Ltd. engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally. It offers starting materials, such as androstenedione, bisnordiol, and 9-hydroxyandrostenedione; intermediates, including sex hormone, progesterone, corticosteroid, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China.
Hubei Goto Biopharm Co.Ltd. Financial Data Overview
| 18.16 | |
| 17.95 | |
| - | |
| 18.16 | |
| 17.68 | |
| 12.019-25.6764 | |
| 2 031 M | |
| 115 M | |
| 547 M | |
| -0.0785 | |
| 0.0009 | |
| 0.126 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'300966',
Type:
'Common Stock',
Name:
'Hubei Goto Biopharm Co.Ltd.',
Exchange:
'SHE',
CurrencyCode:
'CNY',
CurrencyName:
'Renminbi',
CurrencySymbol:
'¥',
CountryName:
'China',
CountryISO:
'CN',
OpenFigi:
NULL,
ISIN:
NULL,
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Hubei Goto Biopharm Co.Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 547 M
- EBITDA 12 027 K
- Earnings Per Share -0.12
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Hubei Goto Biopharm Co.Ltd. Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Hubei Goto Biopharm Co.Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
